Publications by authors named "Nadia Naldi"

Claim this Profile
L
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Michael T Parsons, Emma Tudini, Hongyan Li, Eric Hahnen, Barbara Wappenschmidt, Nadia Naldi

Hum Mutat· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review.
Anna Maria Militello, Teresa Zielli, Daniela Boggiani, Maria Michiara, Nadia Naldi

Front Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
Sarah M Nielsen, Diana M Eccles, Iris L Romero, Fahd Al-Mulla, Judith Balmaña, Nadia Naldi

JCO Precis Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.
Silvia La Monica, Daniele Cretella, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Nadia Naldi

J Exp Clin Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation.
Silvia La Monica, Denise Madeddu, Marcello Tiseo, Valentina Vivo, Maricla Galetti, Nadia Naldi

J Thorac Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
Cecilia Bozzetti, Federico Quaini, Anna Squadrilli, Marcello Tiseo, Caterina Frati, Nadia Naldi

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Benedetta Pellegrino, Mariangela Bella, Maria Michiara, Paola Zanelli, Nadia Naldi

Acta Biomed· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients.
Cecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, Anna Squadrilli, Costanza Lagrasta, Nadia Naldi

Diagn Cytopathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report.
Paola Bordi, Marcello Tiseo, Beatrice Bortesi, Nadia Naldi, Sebastiano Buti

Tumori· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.
Cecilia Bozzetti, Francesca V Negri, Cinzia Azzoni, Nadia Naldi, Rita Nizzoli

Diagn Cytopathol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
Cecilia Bozzetti, Nadia Naldi, Rita Nizzoli, Cinzia Azzoni, Beatrice Bortesi

Lung Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.
Andrea Ambrosini-Spaltro, Nicoletta Campanini, Beatrice Bortesi, Cinzia Azzoni, Nadia Naldi

Appl Immunohistochem Mol Morphol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
Antonino Musolino, Nadia Naldi, Beatrice Bortesi, Debora Pezzuolo, Marzia Capelletti

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Maura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, Marzia Capelletti, Cecilia Bozzetti, Nadia Naldi

Clin Cancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Antonino Musolino, Maria A Bella, Beatrice Bortesi, Maria Michiara, Nadia Naldi

Breast· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Antonino Musolino, Maria Michiara, Maria A Bella, Nadia Naldi, Paola Zanelli

Tumori· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Antonino Musolino, Nadia Naldi, Maria Michiara, Maria A Bella, Paola Zanelli

Breast Cancer Res Treat· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer.
Rita Nizzoli, Annamaria Guazzi, Nadia Naldi, Vittorio Fraciosi, Cecilia Bozzetti

Acta Cytol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
Cecilia Bozzetti, Nicola Personeni, Rita Nizzoli, Annamaria Guazzi, Marcella Flora, Nadia Naldi

Cancer· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
Cecilia Bozzetti, Annamaria Guazzi, Rita Nizzoli, Nadia Naldi, Vittorio Franciosi

Methods Mol Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas.
Rita Nizzoli, Cecilia Bozzetti, Pellegrino Crafa, Nadia Naldi, Annamaria Guazzi

Diagn Cytopathol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer.
Cecilia Bozzetti, Rita Nizzoli, Annamaria Guazzi, Vittorio Franciosi, Leonardo Cattelani, Nadia Naldi

Lung Cancer· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis